Pessary in Singleton Gestations With Short Cervix Without Prior Preterm Birth
- Conditions
- Preterm Birth
- Interventions
- Device: Cervical pessary
- Registration Number
- NCT02716909
- Lead Sponsor
- Federico II University
- Brief Summary
Spontaneous preterm birth (SPTB) remains the number one cause of perinatal mortality in many countries, including the United States. In singleton gestations a short cervical length (CL) on transvaginal ultrasound (TVU) has been shown to be a good predictor of SPTB.
The cervical pessary is a silicone device that has been used to prevent SPTB. The efficacy of cervical pessary has been assessed in several populations including singletons with short CL, unselected twins, twins with a short CL, and triplet pregnancies. Several randomized clinical trials (RCTs) have been published, and several are ongoing. However, no consensus on the use of cervical pessary in pregnancy or guidelines for management have been assessed.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 300
- 18-50 years of age
- Singleton pregnancy (limits the participants to female gender)
- Short cervical length (less than or equal to 25 mm) on second trimester transvaginal ultrasound at 18-23 6/7 weeks gestation
- Multiple gestation
- Prior spontaneous preterm birth 16-36 6/7 weeks
- Ruptured membranes
- Lethal fetal structural anomaly
- Fetal chromosomal abnormality
- Cerclage in place (or planned placement)
- Vaginal bleeding
- Suspicion of chorioamnionitis
- Ballooning of membranes outside the cervix into the vagina or CL = 0 mm on transvaginal ultrasound
- Painful regular uterine contractions
- Placenta previa
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Cervical Pessary Cervical pessary The cervical pessary is a silicone device that has been used to prevent SPTB Pessary will be placed between 18 and 23 6/7 weeks gestation, and will be removed during the 37th week of pregnancy (or earlier, if indicated)
- Primary Outcome Measures
Name Time Method Spontaneous preterm birth (SPTB) <34 weeks Less than 34 weeks gestation Spontaneous preterm delivery less than 34 weeks of gestation
- Secondary Outcome Measures
Name Time Method SPTB <37w Less than 37 weeks gestation SPTB <32w Less than 32 weeks gestation SPTB <28w Less than 32 weeks gestation Gestational age at delivery Time of delivery Latency time of delivery interval from randomization to delivery in days
preterm premature rupture of membranes Less than 34 weeks gestation Type of delivery time of delivery Cesarean delivery, operative vaginal delivery and spontaneous vaginal delivery
Maternal side effects Time of delivery Vaginal discharge, bacterial vaginosis
Birth weight Time of delivery Neonatal death Between birth and 28 days of age perinatal death fetal death after 20 weeks either fetal mortality or neonatal death
Composite adverse perinatal outcome Between birth and 28 days of age Includes necrotizing enterocolitis, Intraventricular hemorrhage (grade 3 or higher), respiratory distress syndrome, bronchopulmonary dysplasia (BPD), retinopathy, blood-culture proven sepsis, and neonatal death
Chorioamnionitis Time of delivery Adminssion to neonatal intensive care unit Between birth and 28 days of age
Trial Locations
- Locations (1)
Gabriele Saccone
🇮🇹Napoli, Italy